
Relibeta Injection
Marketer
Reliance Life Sciences
Salt Composition
Interferon Beta-1A (30mcg)
Overview Relibeta Injection
Multiple sclerosis (MS), a debilitating autoimmune disease attacking the protective myelin sheath surrounding brain and spinal cord neurons, is treated with the prescription medication Relibeta Injection. Administered by a healthcare provider, Relibeta Injection requires adherence to the prescribed dosage. Missed doses should be taken promptly upon recollection; never omit doses, completing the entire treatment course regardless of symptom improvement. Abrupt cessation is unsafe and necessitates prior physician consultation. Common, typically transient side effects include headache, sweating, fever, chills, and flu-like symptoms. Persistent or worsening effects warrant immediate medical attention. Your doctor may recommend regular monitoring of liver and thyroid function, along with blood counts. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your physician immediately. Pregnant or breastfeeding individuals must consult their doctor before commencing treatment.
Uses of Relibeta Injection
Disseminated sclerosis
Major Benefits of Relibeta Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relibeta Injection:
- Headache
- Sweating
- Fever
- Chills
- Flu-like symptoms
How to use Relibeta Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Relibeta Injection works:
Immunomodulating Relibeta Injection lessens the likelihood of developing multiple sclerosis through its anti-inflammatory action and neuroprotective effects.
SAFETY ADVICE
AlcoholUNSAFE
Combining Relibeta Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Relibeta Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Relibeta Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Administering Relibeta Injection might reduce vigilance, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with severe kidney impairment, Relibeta Injection requires careful administration. Dosage modification of Relibeta Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, Relibeta Injection requires careful administration. Dosage modification of Relibeta Injection may be necessary. Physician consultation is advised.
What if you forget to take Relibeta Injection :
Should you forget a Relibeta Injection dose, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Relibeta Injection
Label | Value |
---|---|
Chemical Type | Amino Acids, Peptides, and Their Analogs |
Developing Habits | No. |
Type of Therapy | Cancer Medications |
Action Class | Interferon signaling |